Hyperoside protects human primary melanocytes against H2O2-induced oxidative damage

Yang,Bin; Yang,Qin; Yang,Xin; Yan,Hong‑Bo; Lu,Qi‑Ping

doi:10.3892/mmr.2016.5107

Hyperoside protects human primary melanocytes against H2O2-induced oxidative damage

Authors:
- Bin Yang
- Qin Yang
- Xin Yang
- Hong‑Bo Yan
- Qi‑Ping Lu
View Affiliations

Affiliations: Department of Dermatology, Wuhan General Hospital of Guangzhou Command, Wuhan, Hubei 430070, P.R. China, Department of Laboratory Medicine, Wuhan General Hospital of Guangzhou Command, Wuhan, Hubei 430070, P.R. China, Department of General Surgery, Wuhan General Hospital of Guangzhou Command, Wuhan, Hubei 430070, P.R. China
Published online on: April 12, 2016 https://doi.org/10.3892/mmr.2016.5107
Pages: 4613-4619
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cuscutae semen has been shown to have beneficial effects in the treatment of vitiligo, recorded in the Chinese Pharmacopoeia, whereas the effects of its constituent compounds remains to be elucidated. Using a tetrazolium bromide assay, the present study found that hyperoside (0.5‑200 µg/ml) significantly increased the viability of human melanocytes in a time‑ and dose‑dependent manner. The present study used a cell model of hydrogen peroxide (H2O2)‑induced oxidative damage to examine the effect of hyperoside on human primary melanocytes. The results demonstrated that hyperoside pretreatment for 2 h decreased cell apoptosis from 54.03±9.11 to 17.46±3.10% in the H2O2‑injured melanocytes. The levels of oxidative stress in the mitochondrial membrane potential of the melanocytes increased following hyperoside pretreatment. The mRNA and protein levels of B‑cell lymphoma‑2/Bcl‑2‑associated X protein and caspase 3 were regulated by hyperoside, and phosphoinositide 3‑kinase/AKT and mitogen‑activated protein kinase signaling were also mediated by hyperoside. In conclusion, the results of the present study demonstrated that hyperoside protected the human primary melanocytes against oxidative damage.

View Figures

View References

1	Ruiz-Argüelles A, Brito GJ, Reyes-Izquierdo P, Pérez-Romano B and Sánchez-Sosa S: Apoptosis of melanocytes in vitiligo results from antibody penetration. J Autoimmun. 29:281–286. 2007. View Article : Google Scholar : PubMed/NCBI
2	Silverberg NB: Recent advances in childhood vitiligo. Clin Dermatol. 32:524–530. 2014. View Article : Google Scholar : PubMed/NCBI
3	Guerra L, Dellambra E, Brescia S and Raskovic D: Vitiligo: Pathogenetic hypotheses and targets for current therapies. Curr Drug Metab. 11:451–467. 2010. View Article : Google Scholar : PubMed/NCBI
4	Liu CF, Hu CL, Chiang SS, Tseng KC, Yu RC and Pan TM: Beneficial preventive effects of gastric mucosal lesion for soy-skim milk fermented by lactic acid bacteria. J Agric Food Chem. 57:4433–4438. 2009. View Article : Google Scholar : PubMed/NCBI
5	Hoogduijn MJ, Cemeli E, Ross K, Anderson D, Thody AJ and Wood JM: Melanin protects melanocytes and keratinocytes against H2O2-induced DNA strand breaks through its ability to bind Ca2+. Exp Cell Res. 294:60–67. 2004. View Article : Google Scholar : PubMed/NCBI
6	Valverde P, Manning P, Todd C, McNeil CJ and Thody AJ: Tyrosinase may protect human melanocytes from the cytotoxic effects of the superoxide anion. Exp Dermatol. 5:247–253. 1996. View Article : Google Scholar : PubMed/NCBI
7	Laddha NC, Dwivedi M, Mansuri MS, Gani AR, Ansarullah M, Ramachand AV, Dalai S and Begum R: Vitiligo: Interplay between oxidative stress and immune system. Exp Dermatol. 22:245–250. 2013. View Article : Google Scholar : PubMed/NCBI
8	He X, Yang W, Ye M, Wang Q and Guo D: Differentiation of Cuscuta chinensis and Cuscuta australis by HPLC-DAD-MS analysis and HPLC-UV quantitation. Planta Med. 77:1950–1957. 2011. View Article : Google Scholar : PubMed/NCBI
9	Tang JL, Liu BY and Ma KW: Traditional chinese medicine. The Lancet. 372:1938–1940. 2008. View Article : Google Scholar
10	Yang HM, Shin HK, Kang YH and Kim JK: Cuscuta chinensis extract promotes osteoblast differentiation and mineralization in human osteoblast-like MG-63 cells. J Med Food. 12:85–92. 2009. View Article : Google Scholar : PubMed/NCBI
11	Yen FL, Wu TH, Lin LT, Cham TM and Lin CC: Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats. Food Chem Toxicol. 46:1771–1777. 2008. View Article : Google Scholar : PubMed/NCBI
12	China Pharmacopoeia Committee: Chinese pharmacopoeia. Chinese Medicine Science and Technology Press; Beijing, China: pp. 7402005
13	State Pharmacopoeia Committee: Chinese pharmacopoeia. Chinese Medicine Science and Technology Press; Beijing: pp. 70–71. 2010
14	Jang JY, Kim HN, Kim YR, Choi YH, Kim BW, Shin HK and Choi BT: Aqueous fraction from Cuscuta japonica seed suppresses melanin synthesis through inhibition of the p38 mitogen-activated protein kinase signaling pathway in B16F10 cells. J Ethnopharmacol. 141:338–344. 2012. View Article : Google Scholar : PubMed/NCBI
15	Ye M, Yan Y, Ni X and Qiao L: Studies on the chemical constituents of the herba of Cuscuta chinensis. Zhong Yao Cai. 24:339–341. 2001.In Chinese.
16	Ye M, Yan YN, Qiao L and Ni XM: Studies on chemical constituents of Cuscuta chinensis. Zhongguo Zhong Yao Za Zhi. 27:115–117. 2002.In Chinese.
17	Baek A, Park HJ, Na SJ, Shim DS, Moon JS, Yang Y and Choi YC: The expression of BAFF in the muscles of patients with dermatomyositis. J Neuroimmunol. 249:96–100. 2012. View Article : Google Scholar : PubMed/NCBI
18	VanGuilder HD, Vrana KE and Freeman WM: Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques. 44:619–626. 2008. View Article : Google Scholar : PubMed/NCBI
19	Schallreuter KU, Moore J, Wood JM, et al: In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. The journal of investigative dermatology. Symposium proceedings/the Society for Investigative Dermatology, Inc and European Society for Dermatological Research. 4:91–96. 1999. View Article : Google Scholar : PubMed/NCBI
20	Li CP, Li JH, He SY, Li P and Zhong XL: Roles of Fas/Fasl, Bcl-2/Bax, and Caspase-8 in rat nonalcoholic fatty liver disease pathogenesis. Genet Mol Res. 13:3991–3999. 2014. View Article : Google Scholar : PubMed/NCBI
21	Sharifi S, Barar J, Hejazi MS and Samadi N: Roles of the Bcl-2/Bax ratio, caspase-8 and 9 in resistance of breast cancer cells to paclitaxel. Asian Pac J Cancer Prev. 15:8617–8622. 2014. View Article : Google Scholar : PubMed/NCBI
22	CV SB, Babar SM, Song EJ, Oh E and Yoo YS: Kinetic analysis of the MAPK and PI3K/Akt signaling pathways. Mol Cells. 25:397–406. 2008.
23	Lee ER, Kim JY, Kang YJ, Ahn JY, Kim JH, Kim BW, Choi HY, Jeong MY and Cho SG: Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis. Biochim Biophys Acta. 1763:958–968. 2006. View Article : Google Scholar : PubMed/NCBI
24	Song G, Ouyang G and Bao S: The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 9:59–71. 2005. View Article : Google Scholar : PubMed/NCBI
25	Wada T and Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 23:2838–2849. 2004. View Article : Google Scholar : PubMed/NCBI
26	Wang TJ, An J, Chen XH, Deng QD and Yang L: Assessment of Cuscuta chinensis seeds effect on melanogenesis: Comparison of water and ethanol fractions in vitro and in vivo. J Ethnopharmacol. 154:240–248. 2014. View Article : Google Scholar : PubMed/NCBI
27	Ma H, Zhang X, Mu K, Feng J, Niu X, Liu C and Dang Q: Effects of herb extracts on melanocyte adhesion and migration. Zhongguo pifu xingbingxue zazhi. 18:526–527. 2004.In Chinese.
28	Sabine VS, Crozier C, Brookes CL, Drake C, Piper T, van de Velde CJ, Hasenburg A, Kieback DG, Markopoulos C, Dirix L, et al: Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study. J Clin Oncol. 32:2951–2958. 2014. View Article : Google Scholar : PubMed/NCBI
29	Toda M, Kuo CH, Borman SK, Richardson RM, Inoko A, Inagaki M, Collins A, Schneider K and Ono SJ: Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following FcεRI/CC chemokine receptor 1 cross-talk. J Biol Chem. 287:24516–24524. 2012. View Article : Google Scholar : PubMed/NCBI
30	Cavalcanti BC, da Costa PM, Carvalho AA, Rodrigues FA, Amorim RC, Silva EC, Pohlit AM, Costa-Lotufo LV, Moraes MO and Pessoa C: Involvement of intrinsic mitochondrial pathway in neosergeolide-induced apoptosis of human HL-60 leukemia cells: The role of mitochondrial permeability transition pore and DNA damage. Pharm Biol. 50:980–993. 2012. View Article : Google Scholar : PubMed/NCBI
31	Huang WJ, Bi LY, Li ZZ, Zhang X and Ye Y: Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway. Pharm Biol. 2013.PubMed/NCBI